Liu, Yi
Balaji, Rachna
de Toledo, Marcelo A. Szymanski
Ernst, Sabrina
Hautvast, Petra
Kesdoğan, Aylin B.
Körner, Jannis
Zenke, Martin
Neureiter, Anika
Lampert, Angelika
Funding for this research was provided by:
China Scholarship Council
Alexander von Humboldt-Stiftung (99999.001703/2014-05)
Medizinische Fakultät, RWTH Aachen University (IZKF TN1-1/IA 532001)
Deutsche Forschungsgemeinschaft (363055819/GRK2415)
Bundesministerium für Bildung und Forschung (13GW0334B)
Universitätsklinikum RWTH Aachen
Article History
Received: 6 December 2023
Revised: 16 February 2024
Accepted: 11 March 2024
First Online: 27 March 2024
Declarations
:
: Reprogramming of iPS-cells was performed following informed consent and approved by the local ethics committee at Uniklinik RWTH Aachen. Reprogramming was not part of this study.
: Not applicable.
: Not applicable.
: All authors read and revised the final manuscript. The authors declare that they have no competing interests. AL has a consultancy agreement and a research contract with Grünenthal. There were no conflicts of interest in preparing the manuscript, including financial, institutional and other relationships that might have led to bias.